Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Association between VEGFA gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratio

Full metadata record
DC Field Value Language
dc.contributor.authorYee, Jeong-
dc.contributor.authorKim, Woorim-
dc.contributor.authorChang, Byung Chul-
dc.contributor.authorChung, Jee Eun-
dc.contributor.authorLee, Kyung Eun-
dc.contributor.authorGwak, Hye Sun-
dc.date.accessioned2021-06-22T10:02:24Z-
dc.date.available2021-06-22T10:02:24Z-
dc.date.issued2019-06-
dc.identifier.issn1462-2416-
dc.identifier.issn1744-8042-
dc.identifier.urihttps://scholarworks.bwise.kr/erica/handle/2021.sw.erica/2901-
dc.description.abstractAim: This study was designed to identify the possible effects of VEGFA polymorphisms on the occurrence of bleeding complications in patients with mechanical heart valves who have achieved therapeutic international normalized ratio (INR). Materials & methods: 13 SNPs of VEGFA were analyzed. Uni- and multi-variate analyses were conducted to identify associations between polymorphisms and bleeding complications. Results & conclusion: Patients with the CC genotype of rs35410204 had an approximately tenfold higher bleeding complication than those with the T allele. For rs866236, patients who had wild-type homozygotes showed an approximately 2.9-fold higher bleeding complication than C allele carriers. This study demonstrated that bleeding complications during warfarin therapy are associated with VEGFA polymorphisms in patients with mechanical heart valves.-
dc.format.extent9-
dc.language영어-
dc.language.isoENG-
dc.publisherFUTURE MEDICINE LTD-
dc.titleAssociation between VEGFA gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratio-
dc.typeArticle-
dc.publisher.location영국-
dc.identifier.doi10.2217/pgs-2019-0005-
dc.identifier.scopusid2-s2.0-85068130730-
dc.identifier.wosid000478834800005-
dc.identifier.bibliographicCitationPHARMACOGENOMICS, v.20, no.9, pp 659 - 667-
dc.citation.titlePHARMACOGENOMICS-
dc.citation.volume20-
dc.citation.number9-
dc.citation.startPage659-
dc.citation.endPage667-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClasssci-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.subject.keywordPlusENDOTHELIAL GROWTH-FACTOR-
dc.subject.keywordPlusVASCULAR MALFORMATIONS-
dc.subject.keywordPlusRISK-FACTORS-
dc.subject.keywordPlusANGIOGENESIS-
dc.subject.keywordPlusOUTPATIENTS-
dc.subject.keywordPlusMANAGEMENT-
dc.subject.keywordPlusWARFARIN-
dc.subject.keywordPlusRECEPTOR-
dc.subject.keywordPlusPLASMA-
dc.subject.keywordPlusTARGET-
dc.subject.keywordAuthorbleeding-
dc.subject.keywordAuthormechanical heart valve-
dc.subject.keywordAuthortherapeutic INR-
dc.subject.keywordAuthorVEGFA-
dc.subject.keywordAuthorwarfarin-
dc.identifier.urlhttps://www.futuremedicine.com/doi/10.2217/pgs-2019-0005-
Files in This Item
Go to Link
Appears in
Collections
COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Chung, Jee Eun photo

Chung, Jee Eun
COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)
Read more

Altmetrics

Total Views & Downloads

BROWSE